HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$10.98
Day range
$10.94 - $11.36
Year range
$9.02 - $14.57
Market cap
3.26B USD
Avg Volume
2.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 141.52M | 36.73% |
Operating expense | 103.44M | -4.74% |
Net income | -6.73M | 68.81% |
Net profit margin | -4.75 | 77.22% |
Earnings per share | 0.10 | 242.86% |
EBITDA | 26.98M | 310.81% |
Effective tax rate | 199.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.76M | -10.90% |
Total assets | 786.56M | 2.94% |
Total liabilities | 607.73M | -3.66% |
Total equity | 178.82M | — |
Shares outstanding | 298.69M | — |
Price to book | 18.30 | — |
Return on assets | 8.07% | — |
Return on capital | 10.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.73M | 68.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
517
